Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S N Jones

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Proceedings of the National Academy of Sciences of the United States of America|November 26, 1996
The tumorigenic potential and cell growth characteristics of p53-deficient cells are equivalent in the presence or absence of Mdm2S N Jones, A T Sands, A R Hancock, et al.
Clinical Radiology|November 1, 1989
Non-operative management of gallstones--a preliminary reviewS N Jones, W R Lees, S Garber, et al.
Science (New York, N.Y.)|May 8, 2000
Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathwayC Tournier, P Hess, D D Yang, et al.
Molecular and Cellular Biology|April 21, 2001
Disruption of Ini1 leads to peri-implantation lethality and tumorigenesis in miceC J Guidi, A T Sands, B P Zambrowicz, et al.
Genes & Development|September 20, 2001
Requirement of the JIP1 scaffold protein for stress-induced JNK activationA J Whitmarsh, C Y Kuan, N J Kennedy, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2001
Subnuclear targeting of Runx/Cbfa/AML factors is essential for tissue-specific differentiation during embryonic developmentJ Y Choi, J Pratap, A Javed, et al.
Clinical and Experimental Immunology|April 6, 2005
A transgenic mouse model for studying the clearance of blood-borne pathogens via human complement receptor 1 (CR1)A Repik, S E Pincus, I Ghiran, et al.
Oncogene|January 13, 2015
NKD2, a negative regulator of Wnt signaling, suppresses tumor growth and metastasis in osteosarcomaS Zhao, L Kurenbekova, Y Gao, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Proceedings of the National Academy of Sciences of the United States of America|November 26, 1996
The tumorigenic potential and cell growth characteristics of p53-deficient cells are equivalent in the presence or absence of Mdm2S N Jones, A T Sands, A R Hancock, et al.
Clinical Radiology|November 1, 1989
Non-operative management of gallstones--a preliminary reviewS N Jones, W R Lees, S Garber, et al.
Science (New York, N.Y.)|May 8, 2000
Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathwayC Tournier, P Hess, D D Yang, et al.
Molecular and Cellular Biology|April 21, 2001
Disruption of Ini1 leads to peri-implantation lethality and tumorigenesis in miceC J Guidi, A T Sands, B P Zambrowicz, et al.
Genes & Development|September 20, 2001
Requirement of the JIP1 scaffold protein for stress-induced JNK activationA J Whitmarsh, C Y Kuan, N J Kennedy, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2001
Subnuclear targeting of Runx/Cbfa/AML factors is essential for tissue-specific differentiation during embryonic developmentJ Y Choi, J Pratap, A Javed, et al.
Clinical and Experimental Immunology|April 6, 2005
A transgenic mouse model for studying the clearance of blood-borne pathogens via human complement receptor 1 (CR1)A Repik, S E Pincus, I Ghiran, et al.
Oncogene|January 13, 2015
NKD2, a negative regulator of Wnt signaling, suppresses tumor growth and metastasis in osteosarcomaS Zhao, L Kurenbekova, Y Gao, et al.
Pageof 5